Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 40
MetricValuePeriodScopeSource row
Operating income−¥916m2024-04-01 → 2024-09-30StandaloneOperating income
Operating income−¥593m2023-04-01 → 2023-09-30StandaloneOperating income
Ordinary income−¥916m2024-04-01 → 2024-09-30StandaloneOrdinary income
Ordinary income−¥1.4bn2023-04-01 → 2024-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥599m2023-04-01 → 2023-09-30StandaloneOrdinary income
Profit before tax−¥916m2024-04-01 → 2024-09-30StandaloneIncome before income taxes
Profit before tax−¥599m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Net income−¥917m2024-04-01 → 2024-09-30StandaloneProfit loss
Net income−¥1.4bn2023-04-01 → 2024-03-31StandaloneNet income loss (5-year summary)
Net income−¥600m2023-04-01 → 2023-09-30StandaloneProfit loss
Total assets¥426mat 2024-09-30StandaloneAssets
Total assets¥1.5bnat 2024-03-31StandaloneAssets
Total assets¥491mat 2023-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥110mat 2024-09-30StandaloneLiabilities
Total liabilities¥241mat 2024-03-31StandaloneLiabilities
Net assets / equity¥316mat 2024-09-30StandaloneNet assets
Net assets / equity¥1.2bnat 2024-03-31StandaloneNet assets
Net assets / equity¥403mat 2023-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥349mat 2024-09-30StandaloneCash and deposits
Cash and deposits¥1.4bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥349mat 2024-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.4bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥437mat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥844mat 2023-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥1.1bn2024-04-01 → 2024-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.3bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥619m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥207,0002023-04-01 → 2024-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥918,0002023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥1.9bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥211m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-111.442024-04-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-198.782023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-91.922023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio73.9%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio81.8%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued8,229,900at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued8,229,900at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued6,544,600at 2023-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 319
ItemContextValueUnit
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember-JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember211138000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember-JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember-538000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-1112000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember-407529000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-1067939000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember844341000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1417062000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember436811000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember349122000JPY
Directors compensations sgaPrior1YTDDuration_NonConsolidatedMember40249000JPY
Directors compensations sgaCurrentYTDDuration_NonConsolidatedMember36899000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の5第1項の表の第1号
Place of filing cover pageFilingDateInstant
Original text (Japanese)四国財務局長
Filing date cover pageFilingDateInstant2024-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第15期中(自 2024年4月1日 至 2024年9月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)Delta-Fly Pharma 株式会社
Company name in english cover pageFilingDateInstantDelta-Fly Pharma,Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 江島 淸
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の5
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)088-637-1055(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役 管理部門担当 黒滝 健一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町3丁目11番5号日本橋ライフサイエンスビルディング2 6階
Telephone number nearest place of contact cover pageFilingDateInstant03-6231-1278
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役 管理部門担当 黒滝 健一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE34318
Fund codeFilingDateInstant-
Security codeFilingDateInstant45980
Filer name in japaneseFilingDateInstant
Original text (Japanese)Delta-Fly Pharma株式会社
Filer name in englishFilingDateInstantDelta-Fly Pharma,Inc.
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2024-04-01
Current period end dateFilingDateInstant2024-09-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2025-03-31
Previous fiscal year start dateFilingDateInstant2023-04-01
Comparative period end dateFilingDateInstant2023-09-30
Previous fiscal year end dateFilingDateInstant2024-03-31
Next fiscal year start dateFilingDateInstant-
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2024-03-31pass rounding
balance sheet identitynon_consolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass